NHS Framework Agreement for Aflibercept injection and Ranibizumab injection
NHS Framework Agreement for Proprietary Pharmaceuticals - Afliercept and Ranibizumab ophthalmology products Offer reference number: CM/PHR/17/5561 Period of framework agreement: 1 August 2018 - 31 July 2020 (at the Authority's discretion) for a period or periods up to a total of 24 months
Buyer
NHS England
Value
£1,220,000,000
Published
3 Jul 2018
Closes
10 Aug 2018
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS Framework Agreement for Aflibercept injection and Ranibizumab injection
£1,220,000,000
NHS Framework Agreement for Proprietary Pharmaceuticals - Afliercept and Ranibizumab ophthalmology products Offer reference number: CM/PHR/17/5561 Period of framework agreement: 1 August 2018 - 31 July 2020 (at the Authority's discretion) for a period or periods up to a total of 24 months
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, London · United Kingdom, North East · United Kingdom, North West · United Kingdom, South East · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
3 Jul 2018
Opportunity notice on Contracts Finder
Tender notice · Web page
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · PDF
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
Contains public sector information licensed under the Open Government Licence v3.0.